The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic factors of long-term outcomes after primary chemo-radiotherapy in non-metastatic anal squamous cell carcinoma: An international bicentric cohort.
 
Soledad Iseas
No Relationships to Disclose
 
Diego Martín Prost
No Relationships to Disclose
 
Sarah Bouchereau
No Relationships to Disclose
 
Mariano Golubicki
No Relationships to Disclose
 
Juan Robbio
No Relationships to Disclose
 
Ana Oviedo
No Relationships to Disclose
 
Mariana Coraglio
No Relationships to Disclose
 
Marcela Carballido
No Relationships to Disclose
 
Mirta Kujaruk
No Relationships to Disclose
 
Guillermo Mendez
No Relationships to Disclose
 
Mario Edmundo Barugel
No Relationships to Disclose
 
Enrique Roca
No Relationships to Disclose
 
Louis Gros
No Relationships to Disclose
 
Vincent de Parades
No Relationships to Disclose
 
Nabil Baba-Hamed
No Relationships to Disclose
 
Julien Adam
No Relationships to Disclose
 
Martin C Abba
No Relationships to Disclose
 
Eric Raymond
Employment - Genoscience Pharma; Onward Therapeutics; SCOR; StromaCare
Leadership - AFR-Oncology
Stock and Other Ownership Interests - Genoscience Pharma; neuronax; Oncoethix; SCOR
Consulting or Advisory Role - Celgene; Lilly; Merck Serono; Novartis/Ipsen; Pfizer; PharmaEngine